126 related articles for article (PubMed ID: 8138560)
1. Inhibition of protein-kinase-C--dependent cell proliferation of human lung cancer cell lines by the dihydropyridine dexniguldipine.
Schuller HM; Orloff M; Reznik GK
J Cancer Res Clin Oncol; 1994; 120(6):354-8. PubMed ID: 8138560
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative effects of the Ca2+/calmodulin antagonist B859-35 and the Ca(2+)-channel blocker verapamil on human lung cancer cell lines.
Schüller HM; Orloff M; Reznik GK
Carcinogenesis; 1991 Dec; 12(12):2301-3. PubMed ID: 1747931
[TBL] [Abstract][Full Text] [Related]
3. Amputation and dexniguldipine as treatment for canine appendicular osteosarcoma.
Hahn KA; Legendre AM; Schuller HM
J Cancer Res Clin Oncol; 1997; 123(1):34-8. PubMed ID: 8996538
[TBL] [Abstract][Full Text] [Related]
4. Effect of the dihydropyridine dexniguldipine on the epidermal growth factor-stimulated proliferation of human lung cancer cell lines.
Schuller HM; Orloff M; Reznik GK
Toxicol In Vitro; 1994 Jun; 8(3):455-9. PubMed ID: 20692938
[TBL] [Abstract][Full Text] [Related]
5. Dexniguldipine hydrochloride, a protein-kinase-C-specific inhibitor, affects the cell cycle, differentiation, P-glycoprotein levels, and nuclear protein phosphorylation in Friend erythroleukemia cells.
Patterson KK; Beckman BS; Klotz DM; Mallia CM; Jeter JR
J Cancer Res Clin Oncol; 1996; 122(8):465-75. PubMed ID: 8698746
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cell proliferation, protein kinase C, and phorbol ester-induced fos expression by the dihydropyridine derivative B859-35.
Uberall F; Maly K; Egle A; Doppler W; Hofmann J; Grunicke HH
Cancer Res; 1991 Nov; 51(21):5821-5. PubMed ID: 1718584
[TBL] [Abstract][Full Text] [Related]
7. Effect of suramin on squamous differentiation and apoptosis in three human non-small-cell lung cancer cell lines.
Lokshin A; Levitt ML
J Cell Biochem Suppl; 1996; 24():186-97. PubMed ID: 8806101
[TBL] [Abstract][Full Text] [Related]
8. The aromatic-L-amino acid decarboxylase inhibitor carbidopa is selectively cytotoxic to human pulmonary carcinoid and small cell lung carcinoma cells.
Gilbert JA; Frederick LM; Ames MM
Clin Cancer Res; 2000 Nov; 6(11):4365-72. PubMed ID: 11106255
[TBL] [Abstract][Full Text] [Related]
9. The dihydropyridine dexniguldipine hydrochloride inhibits cleavage and religation reactions of eukaryotic DNA topoisomerase I.
Straub T; Boesenberg C; Gekeler V; Boege F
Biochemistry; 1997 Sep; 36(35):10777-83. PubMed ID: 9271509
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effect of CGP41251, a new selective protein kinase C inhibitor, on human non-small cell lung cancer cells.
Ikegami Y; Yano S; Nakao K
Jpn J Pharmacol; 1996 Jan; 70(1):65-72. PubMed ID: 8822090
[TBL] [Abstract][Full Text] [Related]
11. The omega-hydroxy palmitic acid induced apoptosis in human lung carcinoma cell lines H596 and A549.
Abe A; Yamane M; Yamada H; Sugawara I
J Biochem Mol Biol Biophys; 2002 Feb; 6(1):37-43. PubMed ID: 12186781
[TBL] [Abstract][Full Text] [Related]
12. A somatostatin analogue inhibits MAP kinase activation and cell proliferation in human neuroblastoma and in human small cell lung carcinoma cell lines.
Cattaneo MG; Amoroso D; Gussoni G; Sanguini AM; Vicentini LM
FEBS Lett; 1996 Nov; 397(2-3):164-8. PubMed ID: 8955339
[TBL] [Abstract][Full Text] [Related]
13. Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agents.
Chan DC; Gera L; Stewart JM; Helfrich B; Zhao TL; Feng WY; Chan KK; Covey JM; Bunn PA
Clin Cancer Res; 2002 May; 8(5):1280-7. PubMed ID: 12006549
[TBL] [Abstract][Full Text] [Related]
14. The selective tyrosine kinase inhibitor STI571 inhibits small cell lung cancer growth.
Krystal GW; Honsawek S; Litz J; Buchdunger E
Clin Cancer Res; 2000 Aug; 6(8):3319-26. PubMed ID: 10955819
[TBL] [Abstract][Full Text] [Related]
15. Small cell lung carcinoma exhibits greater phospholipase C-beta1 expression and edelfosine resistance compared with non-small cell lung carcinoma.
Strassheim D; Shafer SH; Phelps SH; Williams CL
Cancer Res; 2000 May; 60(10):2730-6. PubMed ID: 10825148
[TBL] [Abstract][Full Text] [Related]
16. Hydrogen peroxide degradation and selective carbidopa-induced cytotoxicity against human tumor lines.
Gilbert JA; Frederick LM; Pobst LJ; Ames MM
Biochem Pharmacol; 2005 Apr; 69(8):1159-66. PubMed ID: 15794936
[TBL] [Abstract][Full Text] [Related]
17. Indolinone tyrosine kinase inhibitors block Kit activation and growth of small cell lung cancer cells.
Krystal GW; Honsawek S; Kiewlich D; Liang C; Vasile S; Sun L; McMahon G; Lipson KE
Cancer Res; 2001 May; 61(9):3660-8. PubMed ID: 11325836
[TBL] [Abstract][Full Text] [Related]
18. Cyclic adenosine monophosphate-dependent cell type-specific modulation of mitogenic signaling by retinoids in normal and neoplastic lung cells.
Al-Wadei HA; Schuller HM
Cancer Detect Prev; 2006; 30(5):403-11. PubMed ID: 17067750
[TBL] [Abstract][Full Text] [Related]
19. The role of protein kinase C isoenzymes in the growth inhibition caused by bryostatin 1 in human A549 lung and MCF-7 breast carcinoma cells.
Stanwell C; Gescher A; Bradshaw TD; Pettit GR
Int J Cancer; 1994 Feb; 56(4):585-92. PubMed ID: 8112895
[TBL] [Abstract][Full Text] [Related]
20. Carbon dioxide, an important messenger molecule for small cell lung cancer.
Merryman JI; Park PG; Schuller HM
Chest; 1997 Sep; 112(3):779-84. PubMed ID: 9315815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
